Sumit Mukherjee

Background

About Sumit Mukherjee

Preclinical Manager of In Vivo Biology and Principal Scientist leading and directing in vivo POC and other studies and managing external collaborations at R&D of Actinium Pharmaceuticals Inc. Over 2 years of industry experience. • Dynamic individual with a broad knowledge and research and translational experience in radio-ligand therapy, cancer biology and oncoimmunology. • Highly skilled worker with exceptional leadership and team building capabilities: 10+ years in acedemia (PhD+postdoc) and 2+ years in industry. •Track record of presenting and publishing scientific data in a timely and organized fashion: 12 published research articles, 6 as first-author. Being a subject matter expert in preclinical cancer immunology as evidenced by published review articles (being co-corresponding author for one review article). • Frequently peer-reviewed articles for publication as reviewer and guest editor. • Adept in lab and team management, collaborative research, writing research papers, review articles, animal protocols, and training researchers (more than 12 years of experience). • Postdoctoral work focused on a novel immunosuppressive/protumor cancer cell expressing enzyme ART1’s discovery and further developing it as a therapeutic target in NSCLC lung cancers and melanoma tumors utilizing murine in vivo models and patient samples. Led to a first-coauthored article in Science Translational Medicine and multiple grants for the lab. • Postdoc work also focused on investigating ART1's role in other cancer types like EGFR-mutated lung tumors and colorectal cancers. • Doctoral research specialized in natural product-mediated (like dietary polyphenols) therapeutic intervention of cancers by manipulating cancer cell signaling and cancer micro-environment immune system. Studied mechanistic underpinning of cancer cell signaling & tumor microenvironment immunology for therapeutic targeting of brain tumors (GBM) and HPV+ cervical cancer models. Led to multiple first-authored publications and a NCI grant for the lab. • Obtained my Ph.D. in 2018. 10+ years of acedemic experience in cancer biology research including 3+ years of acedemic experience as a Postdoctoral Scientist.